Ustekinumab Biosimilar - Research Grade

Ustekinumab Biosimilar - Research Grade, Host: Humanized, IgG1 kappa
Artikelnummer
ICH4034-10MG
Verpackungseinheit
10mg
Hersteller
Ichorbio

Verfügbarkeit: wird geladen...
Preis wird geladen...
Target: IL-12 and IL-23.

Specificity: Detects human IL-12 and IL-23. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ustekinumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Ustekinumab is a human IgG1κ monoclonal antibody against the p40 subunit of the IL-12 and IL-23 cytokines. Using DNA recombinant technology, ustekinumab is produced in a well characterized recombinant cell line and is purified using standard bio-processing technology. The manufacturing process contains steps for the clearance of viruses. Ustekinumab is comprised of 1326 amino acids and has an estimated molecular mass that ranges from 148,079 to 149,690 Daltons.

Concentration: 1.0 - 5.0 mg/ml.

Formulation: Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

Purity: >95% by SDS-PAGE and HPLC.

Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Mehr Informationen
Artikelnummer ICH4034-10MG
Hersteller Ichorbio
Hersteller Artikelnummer ICH4034-10MG
Verpackungseinheit 10mg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Isotyp IgG1 kappa
Wirt Humanized
Produktinformation (PDF) Download
MSDS (PDF) Download